Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kobayashi Pharmaceutical CoFRA:KOY +0.66%77 3-Year Share Buyback Ratio is 0.70 as of Jun. 2026, which is 17% above its 10-year median of 0.60. GuruFocus rates FRA:KOY with a GF Score™ of 77/100 and a GF Value™ of €26.16 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 960 Consumer Packaged Goods companies, Kobayashi Pharmaceutical Co ranks better than 81.56% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Kobayashi Pharmaceutical Co's current 3-Year Share Buyback Ratio was 0.70%.
The historical rank and industry rank for Kobayashi Pharmaceutical Co's 3-Year Share Buyback Ratio or its related term are showing as below:
FRA:KOY'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: 0 Med: 0.6 Max: 1.7
Current: 0.7
During the past 13 years, Kobayashi Pharmaceutical Co's highest 3-Year Share Buyback Ratio was 1.70%. The lowest was 0.00%. And the median was 0.60%.
FRA:KOY's 3-Year Share Buyback Ratio is ranked better than 81.56% of 960
companies
in the Consumer Packaged Goods industry
Industry Median: -0.8
vs FRA:KOY: 0.70
Kobayashi Pharmaceutical Co (FRA:KOY) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Kobayashi Pharmaceutical Co 3-Year Share Buyback Ratio Related Terms
FRA:KOY vs PG, CL, EL: 3-Year Share Buyback Ratio Comparison
For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kobayashi Pharmaceutical Co 3-Year Share Buyback Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Kobayashi Pharmaceutical Co's 3-Year Share Buyback Ratio falls into.
Kobayashi Pharmaceutical Co 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 0.70 mean?
Kobayashi Pharmaceutical Co (FRA:KOY) has a 3-Year Share Buyback Ratio of 0.70 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Kobayashi Pharmaceutical Co and its competitors. This is 17% above median its historical median of 0.60. According to the industry distribution chart, Kobayashi Pharmaceutical Co ranks #177 out of 960 companies in the Consumer Packaged Goods industry, placing it in the top 18.4%.
Is Kobayashi Pharmaceutical Co's 3-Year Share Buyback Ratio too high?
Kobayashi Pharmaceutical Co's current 3-Year Share Buyback Ratio of 0.70 is 17% above median its 10-year median of 0.60. Based on the distribution chart, Kobayashi Pharmaceutical Co ranks #177 out of 960 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's 3-Year Share Buyback Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Kobayashi Pharmaceutical Co ranks #177 out of 960 companies for 3-Year Share Buyback Ratio. This places Kobayashi Pharmaceutical Co in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Consumer Packaged Goods company?
A good 3-Year Share Buyback Ratio depends on the Consumer Packaged Goods industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Kobayashi Pharmaceutical Co and its competitors. Kobayashi Pharmaceutical Co's current 3-Year Share Buyback Ratio is 0.70, which is 17% above median its own 10-year median of 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co (FRA:KOY) is currently considered Modestly Overvalued. The stock's GF Value™ is €26.16, compared to a current price of €30.40 — trading 16.2% above its estimated fair value. The current 3-Year Share Buyback Ratio is 0.70, which is 17% above median its 10-year median of 0.60. Kobayashi Pharmaceutical Co's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (FRA:KOY), the current 3-Year Share Buyback Ratio is 0.70 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kobayashi Pharmaceutical Co (FRA:KOY) Overvalued in 2026?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be overvalued.
The current stock price of €30.40 is trading 16.2% above its estimated GF Value™ of €26.16.
GuruFocus considers Kobayashi Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for FRA:KOY:
3-Year Share Buyback Ratio: 0.70 (17% above median its 10-year median of 0.60)
GF Value™: €26.16 vs. price of €30.40 (16.2% above fair value)
No single metric tells the full story. See the FRA:KOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
77GF Score
Get the complete analysis for FRA:KOY
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:KOY has been successfully added to your 
